The DEA is delaying the rescheduling of marijuana from Schedule I, despite overwhelming scientific support and recommendations from health authorities. This stalling harms the cannabis industry, patients, and communities affected by marijuana criminalization. Political influences from big pharmaceutical companies contribute to this resistance, prolonging the adverse effects of current drug policies.
The Anti-Legalization Surge: Who’s Really Behind the Pushback?
Despite overwhelming public support, a powerful web of lobbyists, corporations, and fear-peddlers is working overtime to keep weed illegal. This hard-hitting exposé follows the money trail and uncovers the real agenda behind America’s anti-cannabis surge. Spoiler: It’s not about safety, it’s about control.
High Stakes: The $444 Billion Weed Boom
The $444 billion cannabis industry is coming—but not for you. While legacy growers and independent brands fight for survival, Big Tobacco, Big Pharma, and Wall Street are staking their claim. Who wins, who loses, and what the future of weed really looks like. Spoiler: It’s not as green as they promised.
Indiana, Where Weed Bills Go to Die
Indiana lawmakers keep killing cannabis bills while turning a blind eye to alcohol-related deaths and DUIs. With neighboring states cashing in on legalization, Hoosiers are left behind in a puritanical, outdated system. Will Indiana finally wake up, or keep pretending it’s 1950?
Paradise in the Crossfire
The Hawaii Cannabis Expo showcased the ongoing battle for cannabis reform, featuring advocates like cancer survivor Hansel Aquino, who share transformative experiences with cannabis. Despite resistance from law enforcement and bureaucratic hurdles, public support is growing. The movement seeks to dismantle stigma and outdated laws while addressing the thriving black market.
WHAT? Indiana GOP Pushes Bold Bid for Recreational Cannabis Legalization
Indiana Republicans have introduced House Bill 1630, aiming to legalize recreational marijuana for adults over 21 without first establishing a medical program. While proponents argue for its necessity, the bill faces significant opposition from leadership and skepticism in the Senate. Public support for legalization grows, mirroring neighboring states like Michigan and Illinois.